Trends and overview: ELRIG "Robotics and Automation"

Laboratories on the way to end-to-end automation: Robotics, artificial intelligence and automation technology boosted by pandemic

The dock that “thinks” for itself

The world of bulk material handling seems straightforward at first glance: moving, filling, delivering. However, the art of dealing with a variety of different ...

Så involverar du barnen i deras egna klädstil

Har du ett barn hemma som gärna vill bestämma allt själv? Har ni ibland diskussioner om att det inte går att ha shorts på sig i februari? Eller om huruvida over...

Extremely high sample throughput rates

Precision and reliability in automated liquid handling

Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”

It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...

How critical are the “Spermageddon” reports? – Researchers call for action

A much talked about meta-study indicates that sperm concentration in men’s seminal fluid has halved in 40 years. Experts in andrology that Life Science Sweden s...

New rules for diagnostic products, but who will certify them? “An extreme shortage area”

In less than two weeks, new and stricter EU rules will enter into force for thousands of products used in important diagnoses of, among other things, cancer and...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

Effektiv och smärtfri behandling av åderbråck

Nu är våren nästan här och det är dags att ta på sig lättare kläder så som kjolar, klänningar och shorts.

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Nya kit för genetiska fingeravtryck

Qiagens Investigator-serie tar fram genetiska fingeravtryck vid exempelvis brottsutredningar.

Bought a tablet factory – and built his own empire

In 1995, Thomas Eldered was CEO of one of Pharmacia’s factories in the Stockholm area when the Swedish pharmaceutical giant, after a takeover, decided to move i...

Hon får Scheelepriset

Professor Emmanuelle Charpentier tilldelas 2019 års Scheelepris. Hon har spelat en avgörande roll i upptäckten av gensaxen Crispr-Cas9.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

Oxthera får särläkemedelsstatus

EMA ger Oxabact särläkemedelsstatus för behandling av korttarmssyndrom.

Hon får årets Forska Sverige-pris

Umeåforskaren Emmanuelle Charpentier tilldelas Forska Sveriges forskarutmärkelse 2016 för sina upptäckter kring enzymsaxen Crispr-Cas9.

Effektivare nedreglering av gener med siRNA-kit

Kitet använder dicerenzymet för att konvertera ett dubbelsträngat RNA-substrat till siRNA som effektivt tystar ned gener.

Sweden and Denmark – this is how they choose their strategies

Scandinavia’s two major powers in pharmaceutical research have developed strategies for growth in life science, and both countries aim to become world leaders.

Product Specialist at Gradientech AB, Uppsala

Storsatsar på Crispr

Astrazeneca ingår fyra samarbeten kring genmodifieringstekniken Crispr.

We are poor lobbyists

I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...

Nya blodtrycksgener identifierade

Åtta hittills okända gener som påverkar blodtrycket har kartlagts i en stor internationell studie.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.